NO20054102D0 - Vaksiner avledet fra epitelial celle mucin Muc-1 - Google Patents

Vaksiner avledet fra epitelial celle mucin Muc-1

Info

Publication number
NO20054102D0
NO20054102D0 NO20054102A NO20054102A NO20054102D0 NO 20054102 D0 NO20054102 D0 NO 20054102D0 NO 20054102 A NO20054102 A NO 20054102A NO 20054102 A NO20054102 A NO 20054102A NO 20054102 D0 NO20054102 D0 NO 20054102D0
Authority
NO
Norway
Prior art keywords
epithelial cell
vaccines derived
cell mucin
mucin muc
muc
Prior art date
Application number
NO20054102A
Other languages
English (en)
Other versions
NO20054102L (no
Inventor
Paul A Hamblin
Maria De Los Angeles Roch Cura
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20054102D0 publication Critical patent/NO20054102D0/no
Publication of NO20054102L publication Critical patent/NO20054102L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727Mucins, e.g. human intestinal mucin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20054102A 2003-02-28 2005-09-02 Vaksiner avledet fra epitelial celle mucin Muc-1 NO20054102L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0304634.9A GB0304634D0 (en) 2003-02-28 2003-02-28 Vaccines
PCT/EP2004/002007 WO2004076665A2 (en) 2003-02-28 2004-02-26 Vaccines derived from epithelial cell mucin muc-1

Publications (2)

Publication Number Publication Date
NO20054102D0 true NO20054102D0 (no) 2005-09-02
NO20054102L NO20054102L (no) 2005-09-27

Family

ID=9953871

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054102A NO20054102L (no) 2003-02-28 2005-09-02 Vaksiner avledet fra epitelial celle mucin Muc-1

Country Status (18)

Country Link
US (1) US20060147458A1 (no)
EP (1) EP1597368A2 (no)
JP (1) JP2007524352A (no)
KR (1) KR20050107472A (no)
CN (1) CN1753994A (no)
AU (1) AU2004215187A1 (no)
BR (1) BRPI0407601A (no)
CA (1) CA2517062A1 (no)
CO (1) CO5670372A2 (no)
GB (1) GB0304634D0 (no)
IS (1) IS7956A (no)
MA (1) MA27746A1 (no)
MX (1) MXPA05009160A (no)
NO (1) NO20054102L (no)
PL (1) PL378761A1 (no)
RU (1) RU2005125608A (no)
WO (1) WO2004076665A2 (no)
ZA (1) ZA200506548B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0617387D0 (en) * 2006-09-04 2006-10-11 Glaxo Group Ltd Synthetic gene
CN103570821A (zh) * 2012-07-27 2014-02-12 北京智飞绿竹生物制药有限公司 粘蛋白-1抗原性多肽及其作为肿瘤疫苗的用途
CA3036799A1 (en) 2016-09-28 2018-04-05 Bavarian Nordic A/S Compositions and methods for enhancing the stability of transgenes in poxviruses
CN114230655A (zh) * 2021-03-24 2022-03-25 深圳市新靶向生物科技有限公司 一种与食道癌驱动基因突变相关的抗原肽组合及其应用
WO2023122526A1 (en) * 2021-12-20 2023-06-29 Zoetis Services Llc Use of interferon as an adjuvant in vaccines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM322393A0 (en) * 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
US6548643B1 (en) * 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
IL125608A0 (en) * 1998-07-30 1999-03-12 Yeda Res & Dev Tumor associated antigen peptides and use of same as anti-tumor vaccines
DE60030450T2 (de) * 1999-09-08 2007-08-30 Transgene S.A. Von MUC-1 abgeleitete Peptide
GB9930359D0 (en) * 1999-12-22 2000-02-09 Glaxo Group Ltd Novel polypeptides
WO2001057068A1 (en) * 2000-02-01 2001-08-09 The Austin Research Institute Mucin-1 derived antigens and their use in immunotherapy
GB0212046D0 (en) * 2002-05-24 2002-07-03 Glaxo Group Ltd Vaccines
GB0212036D0 (en) * 2002-05-24 2002-07-03 Glaxo Group Ltd Vaccines
GB0321614D0 (en) * 2003-09-15 2003-10-15 Glaxo Group Ltd Vaccines

Also Published As

Publication number Publication date
MA27746A1 (fr) 2006-02-01
CN1753994A (zh) 2006-03-29
AU2004215187A1 (en) 2004-09-10
CO5670372A2 (es) 2006-08-31
GB0304634D0 (en) 2003-04-02
ZA200506548B (en) 2007-12-27
EP1597368A2 (en) 2005-11-23
BRPI0407601A (pt) 2006-02-14
KR20050107472A (ko) 2005-11-11
CA2517062A1 (en) 2004-09-10
WO2004076665A2 (en) 2004-09-10
PL378761A1 (pl) 2006-05-15
RU2005125608A (ru) 2006-03-27
WO2004076665A3 (en) 2005-02-24
US20060147458A1 (en) 2006-07-06
JP2007524352A (ja) 2007-08-30
IS7956A (is) 2005-07-25
MXPA05009160A (es) 2005-10-20
NO20054102L (no) 2005-09-27

Similar Documents

Publication Publication Date Title
DE602005019202D1 (de) Schuppenglas
DE602005002099D1 (de) Luftsack
DE602006010336D1 (de) Luftsystem
DE602006006410D1 (de) Hermetischer verdichter
DE602004005154D1 (de) Vakuumpumpenanlage
DE602004016894D1 (de) Umschlagsdeformation mittels unterteilten Oberflächen
DE602006017343D1 (de) Hermetischer verdichter
DE602005016470D1 (de) Airbagsystem
DE602006010802D1 (de) Hermetischer verdichter
DE602004011420D1 (de) Vereinfachtes Grössenmessgerät
NO20054102D0 (no) Vaksiner avledet fra epitelial celle mucin Muc-1
DE602006021111D1 (de) Hermetischer verdichter
SE0300585L (sv) Brevlåda
ITMI20051729A1 (it) Compressore ermetico
DE602005010485D1 (de) Fahrzeugmontiertes airbagsystem
FR2868113B1 (fr) Fenetre
ITMI20051531A1 (it) Compressore ermetico
DE502004008903D1 (de) Vakuummessbehälter
ITFE20040011A1 (it) Strizza tubetti
FI20030157A0 (fi) Muunneltava tunnuskilpi
UA11051S (uk) Скринька поштова
UA11876S (uk) Вертикальні жалюзі
UA11875S (uk) Вертикальні жалюзі
UA10096S (uk) Конверт з рекламним вікном
SE0401723D0 (sv) Tätningslist

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application